Related Experiment Video
Updated: Aug 6, 2025

Size Matters: Measurement of Capsule Diameter in Cryptococcus neoformans
Published on: February 27, 2018
Cryptococcus neoformans, a global threat to human health
Youbao Zhao1, Leixin Ye2,3, Fujie Zhao4
1College of Veterinary Medicine, Henan Agricultural University, Zhengzhou, 450046, Henan, China. zhaoyoubao@henau.edu.cn.
Cryptococcus neoformans remains a significant global health threat, particularly in HIV-associated cases. Despite treatment advances, limited diagnostics and emerging antifungal resistance necessitate further research into pathogenicity and novel therapies.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Public Health
Background:
- Emerging fungal pathogens, like Cryptococcus neoformans, represent a growing global health concern.
- The World Health Organization identified C. neoformans as a top-priority fungal pathogen.
- Understanding its burden, clinical aspects, and antifungal resistance is crucial for public health.
Purpose of the Study:
- To review the global burden, clinical manifestations, and management of cryptococcal infections over the past two decades.
- To assess the current status of antifungal resistance in Cryptococcus neoformans.
- To identify research gaps and drive efforts for improved diagnostics, therapies, and interventions.
Main Methods:
- Systematic reviews of global HIV-associated cryptococcal infection burden trends.
- Scoping reviews of C. neoformans case reports published since 2000.
- Review of recent updates on diagnosis, antifungal treatment, and drug resistance of cryptococcal infections.
Main Results:
- A reduction in HIV-associated cryptococcal meningitis burden since 2009, attributed to antiretroviral therapies, though it still causes 19% of AIDS deaths.
- Increased incidence of cryptococcal meningitis in Europe, North America, and Latin America.
- Limited diagnostic and treatment options, coupled with emerging antifungal resistance, worsen the public health impact.
Conclusions:
- C. neoformans poses an increasing threat due to its ability to infect immunocompetent individuals and the rise of resistant strains.
- Further research into pathogenicity mechanisms and antifungal resistance/tolerance is essential.
- Developing novel diagnostics, therapeutics, and drug targets is critical for reducing the disease burden.
Related Concept Videos
Fungal Phylum Microsporidia
Diversity of Protists II
Bacterial Phylum Chlamydiae
Threats to Biodiversity
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...

